These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effects of modulator therapies on endocrine complications in adults with cystic fibrosis: a narrative review. Kumar S; Soldatos G; Teede HJ; Pallin M Med J Aust; 2023 Nov; 219(10):496-502. PubMed ID: 37839059 [TBL] [Abstract][Full Text] [Related]
6. [Therapeutics in cystic fibrosis: Clinical revolution and new challenges]. Bardin E; Pranke I; Hinzpeter A; Sermet-Gaudelus I Med Sci (Paris); 2024 Mar; 40(3):258-267. PubMed ID: 38520101 [TBL] [Abstract][Full Text] [Related]
7. Affordable Cystic Fibrosis (CF) Transmembrane Conductance Regulator Modulator Drugs for CF: All CF Lives Worldwide Matter! Zampoli M; Verstraete J; Baird C; Calligaro G; Morrow B Am J Respir Crit Care Med; 2023 Nov; 208(9):915-916. PubMed ID: 37549229 [No Abstract] [Full Text] [Related]
8. What the future holds: cystic fibrosis and aging. Blankenship S; Landis AR; Harrison Williams E; Peabody Lever JE; Garcia B; Solomon G; Krick S Front Med (Lausanne); 2023; 10():1340388. PubMed ID: 38264036 [TBL] [Abstract][Full Text] [Related]
9. Editorial: Optimism grows after 10 years of modulator therapies in Cystic Fibrosis. Fitzgerald DA Paediatr Respir Rev; 2023 Jun; 46():1-2. PubMed ID: 37271654 [No Abstract] [Full Text] [Related]
10. The future of cystic fibrosis treatment: from disease mechanisms to novel therapeutic approaches. Graeber SY; Mall MA Lancet; 2023 Sep; 402(10408):1185-1198. PubMed ID: 37699417 [TBL] [Abstract][Full Text] [Related]
11. Levelling the playing field through the London Network of the UK clinical trials accelerator platform. Matthews J; Dobra R; Wilson G; Allen L; Bossley C; Brendell R; Brugha R; Brown D; Brown S; Cadiente S; Cameron L; Davies G; Dawson C; Elborn S; Hughes D; Longmate J; Macedo P; Pappas L; Pao C; Round C; Ruiz G; Saunders C; Shafi N; Simmonds N; Waller M; Watson D; Davies JC Contemp Clin Trials Commun; 2024 Jun; 39():101301. PubMed ID: 38711836 [TBL] [Abstract][Full Text] [Related]
12. Translational research--from gene to treatment: lessons from cystic fibrosis. Geddes D Clin Med (Lond); 2005; 5(3):258-63. PubMed ID: 16011218 [TBL] [Abstract][Full Text] [Related]
13. Adding fuel to the fire: The growing case for global access to cystic fibrosis transmembrane conductance regulator modulator therapy. Morrow BM; Zampoli M Pediatr Pulmonol; 2024 Jun; ():. PubMed ID: 38869247 [No Abstract] [Full Text] [Related]
14. Genetic surgery for a cystic fibrosis-causing splicing mutation. Bulcaen M; Carlon MS Mol Ther Methods Clin Dev; 2024 Mar; 32(1):101177. PubMed ID: 38261927 [No Abstract] [Full Text] [Related]
15. Compassionate use trials and equitable access to variant-specific treatment for cystic fibrosis. Odem-Davis K; Taylor-Cousar JL Lancet Respir Med; 2024 Aug; ():. PubMed ID: 39151435 [No Abstract] [Full Text] [Related]
16. [Gene therapy: A transformative, multifaceted family of drugs at a crossroads]. Braun S Med Sci (Paris); 2024 Feb; 40(2):119-120. PubMed ID: 38411412 [No Abstract] [Full Text] [Related]
17. Cystic Fibrosis: A Review. Ong T; Ramsey BW JAMA; 2023 Jun; 329(21):1859-1871. PubMed ID: 37278811 [TBL] [Abstract][Full Text] [Related]
18. Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis. Southern KW; Castellani C; Lammertyn E; Smyth A; VanDevanter D; van Koningsbruggen-Rietschel S; Barben J; Bevan A; Brokaar E; Collins S; Connett GJ; Daniels TWV; Davies J; Declercq D; Gartner S; Gramegna A; Hamilton N; Hauser J; Kashirskaya N; Kessler L; Lowdon J; Makukh H; Martin C; Morrison L; Nazareth D; Noordhoek J; O'Neill C; Owen E; Oxley H; Raraigh KS; Raynal C; Robinson K; Roehmel J; Schwarz C; Sermet I; Shteinberg M; Sinha I; Takawira C; van Mourik P; Verkleij M; Waller MD; Duff A J Cyst Fibros; 2023 Jan; 22(1):17-30. PubMed ID: 36916675 [TBL] [Abstract][Full Text] [Related]
19. Genome Editing for Cystic Fibrosis. Wang G Cells; 2023 Jun; 12(12):. PubMed ID: 37371025 [TBL] [Abstract][Full Text] [Related]
20. A refresh of the top 10 research priorities in cystic fibrosis. Rowbotham NJ; Smith S; Elliott ZC; Cupid B; Allen LJ; Cowan K; Allen L; Smyth AR Thorax; 2023 Aug; 78(8):840-843. PubMed ID: 37286236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]